Company Analysis
Sign in

Perspective Therapeutics, Inc. (CATX)

NYSE: CATX · Pharmaceutical Preparations · Seattle, WA · filing with the SEC since 1995
Full chart Alerts Compare
Grade3.9
◀ Past 3.6● Present 3.9▶ Future 4.2
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

9 patents granted to the 5 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Perspective Therapeutics, Inc.’s names, not what it holds today.

Patents granted
9
9 utility, 1976 to Dec 31, 2025
Granted in 2025
1
in the last year the record reads
Applications published
16
7 of them in 2025
Names they are printed under
5
a subsidiary, its own name
By yearGrantedApplications published
'06'07'08'09'12'19'21'22'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology1
Chemical engineering1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name5 counted
Isoray Medical, Inc. a subsidiary
US, as the owner printed on each patent
8 granted
8 published
PERSPECTIVE THERAPEUTICS, INC. its own name
named as the applicant on its applications, in US
0 granted
4 published
Viewpoint Molecular Targeting, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
2 published
Viewpoint Molecular Targeting, Inc. a subsidiary
US, as the owner printed on each patent
0 granted
2 published
PERSPECTIVE THERAPEUTICS, INC. its own name
US, as the owner printed on each patent
1 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
May 27, 202512,312,653Systems and methods for generating leadChemical engineeringPERSPECTIVE THERAPEUTICS, INC.
Apr 12, 202211,298,846Cutting device for brachytherapy seed implantation sleevesMedical technologyIsoray Medical, Inc.
Jun 25, 201910,328,278Device for loading brachytherapy seeds into implantation sleevesMedical technologyIsoray Medical, Inc.
May 12, 20097,531,150Method of separating and purifying cesium-131 from barium carbonateMaterials, metallurgyIsoray Medical, Inc.
Apr 14, 20097,517,508Method of separating and purifying Yttrium-90 from Strontium-90Materials, metallurgyIsoray Medical, Inc.
Mar 31, 20097,510,691Method for improving the recovery of cesium-131 from barium carbonateMaterials, metallurgyIsoray Medical, Inc.
Jan 20, 20097,479,261Method of separating and purifying Cesium-131 from Barium nitrateEngines, pumps, turbinesIsoray Medical, Inc.
Aug 12, 20087,410,458Brachytherapy implant seedsMedical technologyIsoray Medical, Inc.
Jan 8, 20087,316,644Method for preparing particles of radioactive powder containing Cesium-131 for use in brachytherapy sourcesPharmaceuticalsIsoray Medical, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 4, 20252025/0372274SYSTEMS AND METHODS FOR GENERATING RADIONUCLIDESEngines, pumps, turbinesPERSPECTIVE THERAPEUTICS, INC.
Dec 4, 20252025/0368525SYSTEMS AND METHODS FOR GENERATING RADIONUCLIDESChemical engineeringPERSPECTIVE THERAPEUTICS, INC.
Sep 4, 20252025/0277287SYSTEMS AND METHODS FOR GENERATING LEADChemical engineeringPERSPECTIVE THERAPEUTICS, INC.
Jun 12, 20252025/0186632FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDESPharmaceuticalsViewpoint Molecular Targeting, Inc.
Jun 12, 20252025/0186631FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDESPharmaceuticalsViewpoint Molecular Targeting, Inc.
Jun 12, 20252025/0186630FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDESPharmaceuticalsViewpoint Molecular Targeting, Inc.
Feb 20, 20252025/0059621SYSTEMS AND METHODS FOR GENERATING LEADChemical engineeringPERSPECTIVE THERAPEUTICS, INC. · patent 12,312,653 granted from it
Mar 21, 20242024/0091705REMOVAL OF FREE-UNLABELED CATIONIC AND ANIONIC SOLUTION PHASE RADIONUCLIDES FROM RADIOPHARMACEUTICALS USING SOLID-PHASE EXTRACTION TECHNIQUESChemical engineeringViewpoint Molecular Targeting, Inc.
Nov 18, 20212021/0353960DEVICE FOR SHIELDING IMPLANTABLE RADIOACTIVE SOURCES TO ACHIEVE DIRECTIONAL DOSINGMedical technologyIsoray Medical, Inc.
May 2, 20192019/0126065Device for Loading Brachytherapy Seeds into Implantation SleevesMedical technologyIsoray Medical, Inc. · patent 10,328,278 granted from it
What it applied for, 2024 to 2025: Chemical engineering 4 · Pharmaceuticals 3 · Engines, pumps, turbines 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton CATX · research, not advice